Pub Date : 2025-01-01DOI: 10.1016/j.remn.2024.500082
J.J. Rosales , M.L. Domínguez , L. Sancho , E. Prieto , M. de Arcocha , I. Torres , A. Roteta , R. Ramos , G. Quincoces , en nombre del Grupo de Oncología de la SEMNIM
This continuing education analyzes recent advances in Nuclear Medicine focused on the development of new radiopharmaceuticals that improve both the diagnosis and treatment of complex diseases. The focus is on teragnosis, which combines diagnosis and treatment by means of pairs of radiopharmaceuticals directed to the same molecular target, which allows the personalization of treatments.
This first part specifically reviews the teragnostic pairs copper-64/copper-67, lead-212/lead-203 and scandium-44/scandium-47, highlighting their physical characteristics, methods of production and potential clinical applications.
Despite the challenges in their production, their versatility and effectiveness are driving their clinical application in oncology and other diseases. The text also addresses the development of new radiopharmaceuticals and their impact on precision medicine, pointing out future directions and opportunities for research in this field.
{"title":"Estado del arte y perspectivas futuras de nuevos radionúclidos en Medicina Nuclear. Parte I","authors":"J.J. Rosales , M.L. Domínguez , L. Sancho , E. Prieto , M. de Arcocha , I. Torres , A. Roteta , R. Ramos , G. Quincoces , en nombre del Grupo de Oncología de la SEMNIM","doi":"10.1016/j.remn.2024.500082","DOIUrl":"10.1016/j.remn.2024.500082","url":null,"abstract":"<div><div>This continuing education analyzes recent advances in Nuclear Medicine focused on the development of new radiopharmaceuticals that improve both the diagnosis and treatment of complex diseases. The focus is on teragnosis, which combines diagnosis and treatment by means of pairs of radiopharmaceuticals directed to the same molecular target, which allows the personalization of treatments.</div><div>This first part specifically reviews the teragnostic pairs copper-64/copper-67, lead-212/lead-203 and scandium-44/scandium-47, highlighting their physical characteristics, methods of production and potential clinical applications.</div><div>Despite the challenges in their production, their versatility and effectiveness are driving their clinical application in oncology and other diseases. The text also addresses the development of new radiopharmaceuticals and their impact on precision medicine, pointing out future directions and opportunities for research in this field.</div></div>","PeriodicalId":48986,"journal":{"name":"Revista Espanola De Medicina Nuclear E Imagen Molecular","volume":"44 1","pages":"Article 500082"},"PeriodicalIF":1.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143096747","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-01-01DOI: 10.1016/j.remn.2024.500065
N. Aydinbelge-Dizdar , K. Dizdar
Purpose
This study aimed to evaluate the reliability and readability of responses generated by two popular AI-chatbots, ‘ChatGPT-4.0’ and ‘Google Gemini’, to potential patient questions about PET/CT scans.
Materials and methods
Thirty potential questions for each of [18F]FDG and [68Ga]Ga-DOTA-SSTR PET/CT, and twenty-nine potential questions for [68Ga]Ga-PSMA PET/CT were asked separately to ChatGPT-4 and Gemini in May 2024. The responses were evaluated for reliability and readability using the modified DISCERN (mDISCERN) scale, Flesch Reading Ease (FRE), Gunning Fog Index (GFI), and Flesch-Kincaid Reading Grade Level (FKRGL). The inter-rater reliability of mDISCERN scores provided by three raters (ChatGPT-4, Gemini, and a nuclear medicine physician) for the responses was assessed.
Results
The median [min-max] mDISCERN scores reviewed by the physician for responses about FDG, PSMA and DOTA PET/CT scans were 3.5 [2-4], 3 [3-4], 3 [3-4] for ChatGPT-4 and 4 [2-5], 4 [2-5], 3.5 [3-5] for Gemini, respectively. The mDISCERN scores assessed using ChatGPT-4 for answers about FDG, PSMA, and DOTA-SSTR PET/CT scans were 3.5 [3-5], 3 [3-4], 3 [2-3] for ChatGPT-4, and 4 [3-5], 4 [3-5], 4 [3-5] for Gemini, respectively. The mDISCERN scores evaluated using Gemini for responses FDG, PSMA, and DOTA-SSTR PET/CTs were 3 [2-4], 2 [2-4], 3 [2-4] for ChatGPT-4, and 3 [2-5], 3 [1-5], 3 [2-5] for Gemini, respectively. The inter-rater reliability correlation coefficient of mDISCERN scores for ChatGPT-4 responses about FDG, PSMA, and DOTA-SSTR PET/CT scans were 0.629 (95% CI= 0,32-0,812), 0.707 (95% CI = 0.458-0.853) and 0.738 (95% CI = 0.519-0.866), respectively (p< 0.001). The correlation coefficient of mDISCERN scores for Gemini responses about FDG, PSMA, and DOTA-SSTR PET/CT scans were 0.824 (95% CI = 0.677-0.910), 0.881 (95% CI = 0.78-0.94) and 0.847 (95% CI = 0.719-0.922), respectively (p< 0.001). The mDISCERN scores assessed by ChatGPT-4, Gemini, and the physician showed that the chatbots’ responses about all PET/CT scans had moderate to good statistical agreement according to the inter-rater reliability correlation coefficient (p< 0,001). There was a statistically significant difference in all readability scores (FKRGL, GFI, and FRE) of ChatGPT-4 and Gemini responses about PET/CT scans (p< 0,001). Gemini responses were shorter and had better readability scores than ChatGPT-4 responses.
Conclusion
There was an acceptable level of agreement between raters for the mDISCERN score, indicating agreement with the overall reliability of the responses. However, the information provided by AI-chatbots cannot be easily read by the public.
本研究旨在评估两种流行的人工智能聊天机器人“ChatGPT-4.0”和“谷歌Gemini”对患者关于PET/CT扫描的潜在问题所产生的回答的可靠性和可读性。材料与方法于2024年5月分别向ChatGPT-4和Gemini询问[18F]FDG和[68Ga]Ga-DOTA-SSTR PET/CT各30个潜在问题和[68Ga]Ga-PSMA PET/CT 29个潜在问题。采用改进的DISCERN (mDISCERN)量表、Flesch Reading Ease (FRE)、Gunning Fog Index (GFI)和Flesch- kincaid Reading Grade Level (FKRGL)评估问卷的可靠性和可读性。评估了三位评价者(ChatGPT-4、Gemini和一名核医学医师)提供的mDISCERN评分的评分间信度。结果医生对FDG、PSMA和DOTA PET/CT扫描反应的mDISCERN评分中位数[最小-最大]分别为ChatGPT-4的3.5[2-4]、3[3-4]、3 [3-4],Gemini的4[2-5]、4[2-5]、3.5[3-5]。使用ChatGPT-4对FDG、PSMA和DOTA-SSTR PET/CT扫描的答案进行mDISCERN评分,ChatGPT-4的得分分别为3.5[3-5]、3[3-4]、3 [2-3],Gemini的得分分别为4[3-5]、4[3-5]、4[3-5]。使用Gemini评估FDG、PSMA和DOTA-SSTR PET/ ct的mDISCERN得分分别为ChatGPT-4的3[2-4]、2[2-4]、3 [2-4],Gemini的3[2-5]、3[1-5]、3[2-5]。ChatGPT-4对FDG、PSMA和DOTA-SSTR PET/CT扫描反应的mDISCERN评分的评分间信度相关系数分别为0.629 (95% CI= 0,32-0,812)、0.707 (95% CI= 0.458-0.853)和0.738 (95% CI= 0.519-0.866) (p<;0.001)。mDISCERN评分与双子座FDG、PSMA和DOTA-SSTR PET/CT扫描反应的相关系数分别为0.824 (95% CI = 0.677-0.910)、0.881 (95% CI = 0.78-0.94)和0.847 (95% CI = 0.719-0.922) (p<;0.001)。由ChatGPT-4、Gemini和医生评估的mDISCERN分数表明,聊天机器人对所有PET/CT扫描的反应具有中等到良好的统计一致性,根据评分间信度相关系数(p<;0001)。ChatGPT-4和Gemini对PET/CT扫描的所有可读性评分(FKRGL、GFI和FRE)存在统计学上的显著差异(p<;0001)。双子座的回答比ChatGPT-4的回答更短,可读性得分更高。结论评定者对mDISCERN评分的一致性在一个可接受的水平上,表明其总体可靠性是一致的。然而,人工智能聊天机器人提供的信息并不容易被公众阅读。
{"title":"Evaluación de la fiabilidad y legibilidad de las respuestas de los chatbots como recurso de información al paciente para las exploraciones PET-TC más comunes","authors":"N. Aydinbelge-Dizdar , K. Dizdar","doi":"10.1016/j.remn.2024.500065","DOIUrl":"10.1016/j.remn.2024.500065","url":null,"abstract":"<div><h3>Purpose</h3><div>This study aimed to evaluate the reliability and readability of responses generated by two popular AI-chatbots, ‘ChatGPT-4.0’ and ‘Google Gemini’, to potential patient questions about PET/CT scans.</div></div><div><h3>Materials and methods</h3><div>Thirty potential questions for each of [<sup>18</sup>F]FDG and [<sup>68</sup>Ga]Ga-DOTA-SSTR PET/CT, and twenty-nine potential questions for [<sup>68</sup>Ga]Ga-PSMA PET/CT were asked separately to ChatGPT-4 and Gemini in May 2024. The responses were evaluated for reliability and readability using the modified DISCERN (mDISCERN) scale, Flesch Reading Ease (FRE), Gunning Fog Index (GFI), and Flesch-Kincaid Reading Grade Level (FKRGL). The inter-rater reliability of mDISCERN scores provided by three raters (ChatGPT-4, Gemini, and a nuclear medicine physician) for the responses was assessed.</div></div><div><h3>Results</h3><div>The median [min-max] mDISCERN scores reviewed by the physician for responses about FDG, PSMA and DOTA PET/CT scans were 3.5 [2-4], 3 [3-4], 3 [3-4] for ChatGPT-4 and 4 [2-5], 4 [2-5], 3.5 [3-5] for Gemini, respectively. The mDISCERN scores assessed using ChatGPT-4 for answers about FDG, PSMA, and DOTA-SSTR PET/CT scans were 3.5 [3-5], 3 [3-4], 3 [2-3] for ChatGPT-4, and 4 [3-5], 4 [3-5], 4 [3-5] for Gemini, respectively. The mDISCERN scores evaluated using Gemini for responses FDG, PSMA, and DOTA-SSTR PET/CTs were 3 [2-4], 2 [2-4], 3 [2-4] for ChatGPT-4, and 3 [2-5], 3 [1-5], 3 [2-5] for Gemini, respectively. The inter-rater reliability correlation coefficient of mDISCERN scores for ChatGPT-4 responses about FDG, PSMA, and DOTA-SSTR PET/CT scans were 0.629 (95% CI= 0,32-0,812), 0.707 (95% CI<!--> <!-->=<!--> <!-->0.458-0.853) and 0.738 (95% CI<!--> <!-->=<!--> <!-->0.519-0.866), respectively (p<<!--> <!-->0.001). The correlation coefficient of mDISCERN scores for Gemini responses about FDG, PSMA, and DOTA-SSTR PET/CT scans were 0.824 (95% CI<!--> <!-->=<!--> <!-->0.677-0.910), 0.881 (95% CI<!--> <!-->=<!--> <!-->0.78-0.94) and 0.847 (95% CI<!--> <!-->=<!--> <!-->0.719-0.922), respectively (p<<!--> <!-->0.001). The mDISCERN scores assessed by ChatGPT-4, Gemini, and the physician showed that the chatbots’ responses about all PET/CT scans had moderate to good statistical agreement according to the inter-rater reliability correlation coefficient (p<<!--> <!-->0,001). There was a statistically significant difference in all readability scores (FKRGL, GFI, and FRE) of ChatGPT-4 and Gemini responses about PET/CT scans (p<<!--> <!-->0,001). Gemini responses were shorter and had better readability scores than ChatGPT-4 responses.</div></div><div><h3>Conclusion</h3><div>There was an acceptable level of agreement between raters for the mDISCERN score, indicating agreement with the overall reliability of the responses. However, the information provided by AI-chatbots cannot be easily read by the public.</div></div>","PeriodicalId":48986,"journal":{"name":"Revista Espanola De Medicina Nuclear E Imagen Molecular","volume":"44 1","pages":"Article 500065"},"PeriodicalIF":1.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143096585","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-01-01DOI: 10.1016/j.remn.2024.500063
R.M. Angulo Amorese, F.J. Pena Pardo, J.C. Rodríguez Gómez, N. Disotuar Ruiz, M.P. Talavera Rubio, V.M. Poblete García
{"title":"Metástasis ganglionares mediastínicas de cáncer de próstata: mayor precisión diagnóstica de la PET/TC con 18F-DCFPyL frente a la 18F-colina","authors":"R.M. Angulo Amorese, F.J. Pena Pardo, J.C. Rodríguez Gómez, N. Disotuar Ruiz, M.P. Talavera Rubio, V.M. Poblete García","doi":"10.1016/j.remn.2024.500063","DOIUrl":"10.1016/j.remn.2024.500063","url":null,"abstract":"","PeriodicalId":48986,"journal":{"name":"Revista Espanola De Medicina Nuclear E Imagen Molecular","volume":"44 1","pages":"Article 500063"},"PeriodicalIF":1.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143095660","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-01-01DOI: 10.1016/j.remn.2024.500059
M. Simó , O. Persiva , L. Sánchez , J.B. Montoro , I. Sansano , A. Vázquez , F. Ascanio , C. Alemán
Introduction
Histological analysis of the pleura obtained by video-assisted thoracoscopic surgery (VATS) is the best diagnostic technique in the study of neoplastic pleural effusions. This study evaluates the relationship between positron emission tomography (PET)/computed tomography (CT) and VATS findings, the result of the first pleural biopsy, and the final diagnosis of malignancy or non-malignancy.
Methods
Prospective study of consecutive patients with pleural effusions undergoing PET/CT and VATS from October 2013 to December 2023. The following variables were recorded: PET/CT score (nodular pleural thickening, pleural nodules with standardized uptake value (SUV) > 7.5, lung mass or extra pleural malignancy, mammary lymph node with SUV > 4.5 and cardiomegaly); VATS data (drained volume, visceral and parietal pleural thickening, nodules or masses, septa, plaques, fluid appearance, trapped lung, and suspected diagnosis of the procedure), as well as the histological study of the first pleural biopsy (benign or malignant) and the final diagnosis of benign or malignant pleural effusion. A logistic regression study of the variables was performed.
Results
95.8% of the patients with PET/CT and pleuroscopy not suggestive of malignancy had non-malignant histological findings, while 93.2% of the patients with PET/CT and pleuroscopy suggestive of malignancy had malignant histological findings. PET/CT, pleuroscopy, and the result of the first pleural biopsy showed a significant association with the final diagnosis of pleural effusion.
Conclusions
There is a strong association between PET/CT findings, VATS and pleural histology.
{"title":"Asociación de los hallazgos de la PET-TC y la VATS con la histología pleural en el estudio del derrame pleural","authors":"M. Simó , O. Persiva , L. Sánchez , J.B. Montoro , I. Sansano , A. Vázquez , F. Ascanio , C. Alemán","doi":"10.1016/j.remn.2024.500059","DOIUrl":"10.1016/j.remn.2024.500059","url":null,"abstract":"<div><h3>Introduction</h3><div>Histological analysis of the pleura obtained by video-assisted thoracoscopic surgery (VATS) is the best diagnostic technique in the study of neoplastic pleural effusions. This study evaluates the relationship between positron emission tomography (PET)/computed tomography (CT) and VATS findings, the result of the first pleural biopsy, and the final diagnosis of malignancy or non-malignancy.</div></div><div><h3>Methods</h3><div>Prospective study of consecutive patients with pleural effusions undergoing PET/CT and VATS from October 2013 to December 2023. The following variables were recorded: PET/CT score (nodular pleural thickening, pleural nodules with standardized uptake value (SUV) ><!--> <!-->7.5, lung mass or extra pleural malignancy, mammary lymph node with SUV ><!--> <!-->4.5 and cardiomegaly); VATS data (drained volume, visceral and parietal pleural thickening, nodules or masses, septa, plaques, fluid appearance, trapped lung, and suspected diagnosis of the procedure), as well as the histological study of the first pleural biopsy (benign or malignant) and the final diagnosis of benign or malignant pleural effusion. A logistic regression study of the variables was performed.</div></div><div><h3>Results</h3><div>95.8% of the patients with PET/CT and pleuroscopy not suggestive of malignancy had non-malignant histological findings, while 93.2% of the patients with PET/CT and pleuroscopy suggestive of malignancy had malignant histological findings. PET/CT, pleuroscopy, and the result of the first pleural biopsy showed a significant association with the final diagnosis of pleural effusion.</div></div><div><h3>Conclusions</h3><div>There is a strong association between PET/CT findings, VATS and pleural histology.</div></div>","PeriodicalId":48986,"journal":{"name":"Revista Espanola De Medicina Nuclear E Imagen Molecular","volume":"44 1","pages":"Article 500059"},"PeriodicalIF":1.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143096586","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-01-01DOI: 10.1016/j.remn.2024.500066
F.G. García-García , N. Cassinello Fernández , J. Rodríguez Romera , R. Martí Fernández , M. Lapeña Rodríguez , R. Alfonso Ballester , R. Díaz Expósito , J. Ortega Serrano
Background and objectives
To assess the feasibility of performing selective parathyroidectomy without intraoperative parathyroid hormone (PTHio) determination when first-line preoperative localization tests (ultrasonography and [99mTc]Tc-MIBI) are negative and/or discordant, and second-line [18F]F-Colina PET-CT, is positive.
Materials and methods
Retrospective cohort study, including patients with negative or discordant ultrasound and MIBI scans and positive [18F]F-Colina PET-CT, who underwent selective parathyroidectomy between 2019 and 2022. Groups were compared based on PTHio determination. Study variables were: gender, mean age, biochemical cure assessed by PTH value (pg/mL) and corrected calcium by albumin (mg/dL) at 6 months post-surgery follow-up, and histopathological analysis.
Results
The final sample included 42 patients. At 6 months post-surgery, in the PTHio group (20 patients), PTH values were 64.50 pg/mL and calcium 9.30 pg/mL, with 19 adenomas and 1 hyperplasia found. In the non-PTHio group (22 patients), PTH values were 61 pg/mL and calcium 9.37 pg/mL, with 22 adenomas found. No statistically significant differences were found between both groups.
Conclusions
Based on the results obtained in our patient cohort, selective parathyroidectomy could be considered with negative or discordant first-line tests and positive [18F]F-Colina PET-CT, without intraoperative PTH determination.
{"title":"PET-TC [18F]F-Colina y PTH intraoperatoria en el tratamiento quirúrgico del hiperparatiroidismo primario sin localización preoperatoria","authors":"F.G. García-García , N. Cassinello Fernández , J. Rodríguez Romera , R. Martí Fernández , M. Lapeña Rodríguez , R. Alfonso Ballester , R. Díaz Expósito , J. Ortega Serrano","doi":"10.1016/j.remn.2024.500066","DOIUrl":"10.1016/j.remn.2024.500066","url":null,"abstract":"<div><h3>Background and objectives</h3><div>To assess the feasibility of performing selective parathyroidectomy without intraoperative parathyroid hormone (PTHio) determination when first-line preoperative localization tests (ultrasonography and [<sup>99m</sup>Tc]Tc-MIBI) are negative and/or discordant, and second-line [<sup>18</sup>F]F-Colina PET-CT, is positive.</div></div><div><h3>Materials and methods</h3><div>Retrospective cohort study, including patients with negative or discordant ultrasound and MIBI scans and positive [<sup>18</sup>F]F-Colina PET-CT, who underwent selective parathyroidectomy between 2019 and 2022. Groups were compared based on PTHio determination. Study variables were: gender, mean age, biochemical cure assessed by PTH value (pg/mL) and corrected calcium by albumin (mg/dL) at 6 months post-surgery follow-up, and histopathological analysis.</div></div><div><h3>Results</h3><div>The final sample included 42 patients. At 6 months post-surgery, in the PTHio group (20 patients), PTH values were 64.50 pg/mL and calcium 9.30 pg/mL, with 19 adenomas and 1 hyperplasia found. In the non-PTHio group (22 patients), PTH values were 61 pg/mL and calcium 9.37 pg/mL, with 22 adenomas found. No statistically significant differences were found between both groups.</div></div><div><h3>Conclusions</h3><div>Based on the results obtained in our patient cohort, selective parathyroidectomy could be considered with negative or discordant first-line tests and positive [<sup>18</sup>F]F-Colina PET-CT, without intraoperative PTH determination.</div></div>","PeriodicalId":48986,"journal":{"name":"Revista Espanola De Medicina Nuclear E Imagen Molecular","volume":"44 1","pages":"Article 500066"},"PeriodicalIF":1.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143105218","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-01-01DOI: 10.1016/j.remn.2024.500039
I. Martínez-Rodríguez, F. Gómez-de la Fuente, A. Sánchez-Salmón, M. Pombo-López, A. Bota-Bota, R. Quirce
{"title":"18F-FDG PET/TC en la estadificación, evaluación terapéutica y seguimiento de un sarcoma prostático","authors":"I. Martínez-Rodríguez, F. Gómez-de la Fuente, A. Sánchez-Salmón, M. Pombo-López, A. Bota-Bota, R. Quirce","doi":"10.1016/j.remn.2024.500039","DOIUrl":"10.1016/j.remn.2024.500039","url":null,"abstract":"","PeriodicalId":48986,"journal":{"name":"Revista Espanola De Medicina Nuclear E Imagen Molecular","volume":"44 1","pages":"Article 500039"},"PeriodicalIF":1.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143105219","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-01-01DOI: 10.1016/j.remn.2024.500068
A. Garcia Garcia , A.P. Caresia Aróztegui , S. Martínez Román
{"title":"Uso de propranolol en 18F-FDG-PET/TC para el diagnóstico diferencial de grasa parda en una paciente con antecedente de adenocarcinoma de cérvix uterino","authors":"A. Garcia Garcia , A.P. Caresia Aróztegui , S. Martínez Román","doi":"10.1016/j.remn.2024.500068","DOIUrl":"10.1016/j.remn.2024.500068","url":null,"abstract":"","PeriodicalId":48986,"journal":{"name":"Revista Espanola De Medicina Nuclear E Imagen Molecular","volume":"44 1","pages":"Article 500068"},"PeriodicalIF":1.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143095659","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-01-01DOI: 10.1016/j.remn.2024.500028
L. Bian , C. Yang , S.-w. Yin , C.-f. Ni
{"title":"Efecto antitumoral de la vertebroplastia en la metástasis vertebral basado en el análisis cuantitativo de la PET/TC con 18F-FDG","authors":"L. Bian , C. Yang , S.-w. Yin , C.-f. Ni","doi":"10.1016/j.remn.2024.500028","DOIUrl":"10.1016/j.remn.2024.500028","url":null,"abstract":"","PeriodicalId":48986,"journal":{"name":"Revista Espanola De Medicina Nuclear E Imagen Molecular","volume":"44 1","pages":"Article 500028"},"PeriodicalIF":1.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143095661","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-01-01DOI: 10.1016/j.remn.2024.500067
D. Tercero Garrido , M.V. Guiote Moreno , C. Rodelo-Haad , P.I. Contreras Puertas , S. Soriano Cabrera , M.D. Albalá González
Objective
To assess the usefulness of peritoneal cavity scintigraphy and the contribution of SPECT/CT in patients on peritoneal dialysis with suspected leak.
Methodology
An observational case series study is carried out. It consists of a longitudinal, retrospective and descriptive study. 11 patients on peritoneal dialysis were studied and it was realiced a peritoneal cavity scintigraphy test and SPECT/CT to evaluate a peritoneal leak.
Results
In 54,5% of the patients, a positive study of peritoneal leak was obtained. The most frequent localitations were in the abdominal wall at the catheter entry level and the inguinal hernia. In the cases with sintomatology like pain and celullitis of the subcutaneous tract of the cateter the frequent of leak was 100%. There was a change in therapeutic management in patients with a positive study. There was not relevant changes in initial dialysis regimen in patients with a negative study. In this cases, except for one patient who required hemodialysis, all patients experienced clinical improvement.
Conclusions
Peritoneal scintigraphy and SPECT/CT study are non-invasive techniques that allow an adequate diagnosis and subsequent management of peritoneal leak.
{"title":"Gammagrafía peritoneal y SPECT/CT en el diagnóstico de fugas en pacientes en diálisis peritoneal","authors":"D. Tercero Garrido , M.V. Guiote Moreno , C. Rodelo-Haad , P.I. Contreras Puertas , S. Soriano Cabrera , M.D. Albalá González","doi":"10.1016/j.remn.2024.500067","DOIUrl":"10.1016/j.remn.2024.500067","url":null,"abstract":"<div><h3>Objective</h3><div>To assess the usefulness of peritoneal cavity scintigraphy and the contribution of SPECT/CT in patients on peritoneal dialysis with suspected leak.</div></div><div><h3>Methodology</h3><div>An observational case series study is carried out. It consists of a longitudinal, retrospective and descriptive study. 11 patients on peritoneal dialysis were studied and it was realiced a peritoneal cavity scintigraphy test and SPECT/CT to evaluate a peritoneal leak.</div></div><div><h3>Results</h3><div>In 54,5% of the patients, a positive study of peritoneal leak was obtained. The most frequent localitations were in the abdominal wall at the catheter entry level and the inguinal hernia. In the cases with sintomatology like pain and celullitis of the subcutaneous tract of the cateter the frequent of leak was 100%. There was a change in therapeutic management in patients with a positive study. There was not relevant changes in initial dialysis regimen in patients with a negative study. In this cases, except for one patient who required hemodialysis, all patients experienced clinical improvement.</div></div><div><h3>Conclusions</h3><div>Peritoneal scintigraphy and SPECT/CT study are non-invasive techniques that allow an adequate diagnosis and subsequent management of peritoneal leak.</div></div>","PeriodicalId":48986,"journal":{"name":"Revista Espanola De Medicina Nuclear E Imagen Molecular","volume":"44 1","pages":"Article 500067"},"PeriodicalIF":1.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143135593","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}